AB Science presented new preclinical data for masitinib in ALS at the 2019 Muscular Dystrophy Association Conference

NEXT STORY
Roche reports a strong start in 2019 and raises the outlook for the full-year
PREV STORY
XORTX Shares Findings of Diabetes Study in Youths Supporting High Uric Acid Advances Kidney Disease Progression
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

NEW YORK, Sept. 05, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a late-stage clinical ...

author_avatar
NASDAQ Market News

Medical Laser Systems Market Forecasts – 14.7% CAGR to 2025, Says Global Market Insights, Inc.

author_avatar
NASDAQ Market News

Eisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018

TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: ...

author_avatar
NASDAQ Market News